08/06/2026
The National Alopecia Areata Foundation wants to hear from you. In 2026, CMS clarified that Medicare Part D plans should cover FDA-approved JAK inhibitors for severe alopecia areata, but some patients still face denials and delays.
If you or someone you know has Medicare Part D and has been denied coverage, share your experience:
We are inviting members of our community to join our Lived Experience Network. By sharing your information, you may be considered for opportunities such as focus groups, interviews, patient advisory panels, content review, media opportunities, and other engagements that help inform our work and that...